Related Experiment Video
Updated: Mar 19, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Skeletal muscle and plasma concentrations of cefazolin during complex paediatric spinal surgery
A S Himebauch1, W N Sankar2, J M Flynn2
1Department of Anesthesiology and Critical Care Medicine Center for Clinical Pharmacology himebaucha@email.chop.edu.
Insights
Cefazolin dosing for pediatric spinal surgery achieved high concentrations against MSSA but was insufficient for Gram-negative pathogens, indicating potential risks for surgical site infections (SSIs). Further research is needed to optimize prophylaxis.
Area of Science:
- Pharmacology
- Pediatric Surgery
- Infectious Disease
Background:
- Surgical site infections (SSIs) pose significant risks to pediatric patients undergoing spinal instrumentation.
- Limited prospective data exist on the efficacy of prophylactic cefazolin in this specific population.
- Understanding cefazolin's pharmacokinetics and tissue disposition is crucial for optimizing infection prevention.
Purpose of the Study:
- To evaluate the pharmacokinetics and skeletal muscle disposition of prophylactic cefazolin in children undergoing complex spinal surgery.
- To determine if standard cefazolin dosing achieves adequate concentrations for surgical site infection (SSI) prophylaxis in pediatric patients.
Main Methods:
- A prospective pharmacokinetic study involving 17 children with adolescent idiopathic scoliosis undergoing posterior spinal fusion.
- Serial plasma and skeletal muscle microdialysis samples were collected to measure unbound cefazolin concentrations.
- Non-compartmental pharmacokinetic analysis was performed to assess drug exposure and time above the minimum inhibitory concentration (MIC).
Main Results:
- Skeletal muscle cefazolin concentrations peaked rapidly after dosing, reaching median values of 37.6-40.5 µg/mL.
- Target concentrations for methicillin-sensitive Staphylococcus aureus (MSSA) were exceeded for 98.9% of intraoperative time.
- Target concentrations for Gram-negative pathogens were only exceeded for 58.3% of intraoperative time.
Conclusions:
- The standard cefazolin dosing strategy in this pediatric cohort provided adequate intraoperative concentrations against MSSA.
- However, the achieved skeletal muscle concentrations were likely insufficient for effective prophylaxis against Gram-negative pathogens.
- Current cefazolin dosing may not fully protect against Gram-negative SSIs in pediatric spinal fusion surgery.
Background:
Surgical site infections (SSIs) can have devastating consequences for children who undergo spinal instrumentation. Prospective evaluations of prophylactic cefazolin in this population are limited. The purpose of this study was to describe the pharmacokinetics and skeletal muscle disposition of prophylactic cefazolin in a paediatric population undergoing complex spinal surgery.
Methods:
This prospective pharmacokinetic study included 17 children with adolescent idiopathic scoliosis undergoing posterior spinal fusion, with a median age of 13.8 [interquartile range (IQR) 13.4-15.4] yr and a median weight of 60.6 (IQR 50.8-66.0) kg. A dosing strategy consistent with published guidelines was used. Serial plasma and skeletal muscle microdialysis samples were obtained during the operative procedure and unbound cefazolin concentrations measured. Non-compartmental pharmacokinetic analyses were performed. The amount of time that the concentration of unbound cefazolin exceeded the minimal inhibitory concentration for bacterial growth for selected SSI pathogens was calculated.
Results:
Skeletal muscle concentrations peaked at a median of 37.6 (IQR 26.8-40.0) µg ml(-1) within 30-60 min after the first cefazolin 30 mg kg(-1) dose. For patients who received a second 30 mg kg(-1) dose, the peak concentrations reached a median of 40.5 (IQR 30.8-45.7) µg ml(-1) within 30-60 min. The target cefazolin concentrations for SSI prophylaxis for meticillin-sensitive Staphylococcus aureus (MSSA) and Gram-negative pathogens were exceeded in skeletal muscle 98.9 and 58.3% of the intraoperative time, respectively.
Conclusions:
For children with adolescent idiopathic scoliosis undergoing posterior spinal fusion, the cefazolin dosing strategy used in this study resulted in skeletal muscle concentrations that were likely not to be effective for intraoperative SSI prophylaxis against Gram-negative pathogens.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pharmacokinetics in Pediatric Patients: Drug Distribution
Local Anesthetics: Clinical Application as Spinal Anesthesia